Dare Bioscience, Inc. — Form 8-K
Filed September 9, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
Filing metadata indicates a Form 8-K filed September 9, 2026, containing Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The actual substance of the disclosure cannot be determined from the document index alone; the exhibit content (ex99-1.htm and 40 graphics) is not provided in this filing extract.
Why this rating
Filing structure visible but core disclosure content absent. Cannot assess materiality without actual disclosure text or exhibit content details.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from September 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.